Literature DB >> 4148417

Trimethoprim-sulfamethoxazole in the treatment and prevention of purulent exacerbations of chronic bronchitis.

A Pines.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4148417     DOI: 10.1093/infdis/128.supplement_3.s706

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.

Authors:  A P Sachs; G H Koëter; K H Groenier; D van der Waaij; J Schiphuis; B Meyboom-de Jong
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

Review 2.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

3.  Head-to-head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease.

Authors:  Christopher Jd Threapleton; Sadia Janjua; Rebecca Fortescue; Emma H Baker
Journal:  Cochrane Database Syst Rev       Date:  2019-05-24

4.  Antibiotics for exacerbations of chronic obstructive pulmonary disease.

Authors:  Daniela J Vollenweider; Anja Frei; Claudia A Steurer-Stey; Judith Garcia-Aymerich; Milo A Puhan
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29

Review 5.  Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review.

Authors:  Adam J Shapiro; Maimoona A Zariwala; Thomas Ferkol; Stephanie D Davis; Scott D Sagel; Sharon D Dell; Margaret Rosenfeld; Kenneth N Olivier; Carlos Milla; Sam J Daniel; Adam J Kimple; Michele Manion; Michael R Knowles; Margaret W Leigh
Journal:  Pediatr Pulmonol       Date:  2015-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.